Skip to content

Clinical trials

Melanoma trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Status: Unknown status Country / region: China Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20133
20141
20152
20164
20174
20184
20194
20206
202110
202211
20236
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status57

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Cancer Hospital & Institute16
Fudan University3
Shanghai Junshi Bioscience Co., Ltd.3
BGI, China2
OrienGene Biotechnology Ltd.2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
Yong Chen2
Beijing Immunochina Medical Science & Technology Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Di Wu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma57
Lung Neoplasms6
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung4
Ovarian Neoplasms4
Colorectal Neoplasms3
Head and Neck Neoplasms3
Neoplasm Metastasis3
Urinary Bladder Neoplasms3
Carcinoma2

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.